Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026
Date of Filing: September 10, 2026
Principal Executive Office: Caesarea, Israel
This filing reports a material corporate event: the issuance of a press release announcing regulatory approval to market the ProSense® device in China.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a current report of a specific event and does not contain financial statements or performance metrics.
Material Changes
- Regulatory Milestone: Icecure Medical received regulatory approval to market its ProSense® product in China.
- Market Expansion: This approval enables the Company to enter the Chinese market for this specific device.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.1) detailing the China approval. No specific financial guidance, forward-looking revenue projections, or management outlook regarding future performance is included in the text of this Form 6-K.
Risks and Contingencies: The filing text does not explicitly list new risks or contingencies associated with this event, though standard regulatory and market entry risks are implied by the nature of the announcement.
Investor Verification Checklist
- Verify the specific regulatory body in China that granted the approval for ProSense®.
- Review the full text of the press release (Exhibit 99.1) for details on commercialization timelines and launch plans in China.
- Assess the potential revenue impact of the Chinese market on the Company's overall financial outlook.
- Confirm if there are any conditions or restrictions attached to the regulatory approval.